109 related articles for article (PubMed ID: 1680025)
1. Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma.
Harning R; Mainolfi E; Bystryn JC; Henn M; Merluzzi VJ; Rothlein R
Cancer Res; 1991 Sep; 51(18):5003-5. PubMed ID: 1680025
[TBL] [Abstract][Full Text] [Related]
2. Circulating forms of ICAM-3 (cICAM-3). Elevated levels in autoimmune diseases and lack of association with cICAM-1.
Martin S; Rieckmann P; Melchers I; Wagner R; Bertrams J; Voskuyl AE; Roep BO; Zielasek J; Heidenthal E; Weichselbraun I
J Immunol; 1995 Feb; 154(4):1951-5. PubMed ID: 7836774
[TBL] [Abstract][Full Text] [Related]
3. Differential patterns of circulating intercellular adhesion molecule-1 (cICAM-1) and vascular cell adhesion molecule-1 (cVCAM-1) during liver allograft rejection.
Lang T; Krams SM; Villanueva JC; Cox K; So S; Martinez OM
Transplantation; 1995 Feb; 59(4):584-9. PubMed ID: 7533349
[TBL] [Abstract][Full Text] [Related]
4. A form of circulating ICAM-1 in human serum.
Rothlein R; Mainolfi EA; Czajkowski M; Marlin SD
J Immunol; 1991 Dec; 147(11):3788-93. PubMed ID: 1682385
[TBL] [Abstract][Full Text] [Related]
5. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
Mrowka C; Heintz B; Sieberth HG
Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of circulating ICAM-1 are increased in Hodgkin's disease.
Gruss HJ; Dölken G; Brach MA; Mertelsmann R; Herrmann F
Leukemia; 1993 Aug; 7(8):1245-9. PubMed ID: 8102418
[TBL] [Abstract][Full Text] [Related]
7. Detection of circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in Wegener's granulomatosis, systemic lupus erythematosus and chronic renal failure.
Mrowka C; Sieberth HG
Clin Nephrol; 1995 May; 43(5):288-96. PubMed ID: 7543387
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of intercellular adhesion molecule-1 (ICAM-1) and soluble interleukin 2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukaemia.
Musolino C; Alonci A; Allegra A; Bellomo G; Spatari G; Pernice F; Squadrito G; Quartarone C; Tringali O; Quartarone M
Riv Eur Sci Med Farmacol; 1996; 18(3):113-8. PubMed ID: 9177607
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous measurement of circulating intercellular adhesion molecule-1 and serum copper zinc superoxide dismutase activity in patients with malignant melanoma.
Wollina U; Karte K; Olbertz K; Hipler UC
Oncol Rep; 1998; 5(2):473-6. PubMed ID: 9468582
[TBL] [Abstract][Full Text] [Related]
10. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
López-Lerma I; Estrach MT
J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma.
Kageshita T; Yoshii A; Kimura T; Kuriya N; Ono T; Tsujisaki M; Imai K; Ferrone S
Cancer Res; 1993 Oct; 53(20):4927-32. PubMed ID: 8104688
[TBL] [Abstract][Full Text] [Related]
12. Circulating adhesion molecules in tuberculosis.
Lai CK; Wong KC; Chan CH; Ho SS; Chung SY; Haskard DO; Lai KN
Clin Exp Immunol; 1993 Dec; 94(3):522-6. PubMed ID: 7504602
[TBL] [Abstract][Full Text] [Related]
13. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.
Boyano MD; Garcia-Vázquez MD; López-Michelena T; Gardeazabal J; Bilbao J; Cañavate ML; Galdeano AG; Izu R; Díaz-Ramón L; Raton JA; Díaz-Pérez JL
Br J Cancer; 2000 Oct; 83(7):847-52. PubMed ID: 10970683
[TBL] [Abstract][Full Text] [Related]
14. Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma.
Bosserhoff AK; Kaufmann M; Kaluza B; Bartke I; Zirngibl H; Hein R; Stolz W; Buettner R
Cancer Res; 1997 Aug; 57(15):3149-53. PubMed ID: 9242442
[TBL] [Abstract][Full Text] [Related]
15. Circulating intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin in urological malignancies.
Perabo F; Sharma S; Gierer R; Wirger A; Fimmers R; Steiner G; Adam M; Schultze-Seemann W
Indian J Cancer; 2001 Mar; 38(1):1-7. PubMed ID: 14758878
[TBL] [Abstract][Full Text] [Related]
16. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of serum levels of soluble intercellular adhesion molecule-1 and soluble L-selectin in malignant melanoma.
Yamada M; Yanaba K; Takehara K; Sato S
Arch Dermatol Res; 2005 Dec; 297(6):256-60. PubMed ID: 16222535
[TBL] [Abstract][Full Text] [Related]
18. Circulating adhesion molecules as prognostic factors for cutaneous melanoma.
Schaider H; Rech-Weichselbraun I; Richtig E; Seidl H; Soyer HP; Smolle J; Kerl H
J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):209-13. PubMed ID: 9039170
[TBL] [Abstract][Full Text] [Related]
19. Soluble intercellular adhesion molecule-1 as a prognostic marker for stage II colorectal cancer patients.
Toiyama Y; Miki C; Inoue Y; Okugawa Y; Koike Y; Yokoe T; Tanaka K; Kusunoki M
Ann Surg Oncol; 2008 Jun; 15(6):1617-24. PubMed ID: 18368454
[TBL] [Abstract][Full Text] [Related]
20. Elevated levels of circulating intercellular adhesion molecule-3 (cICAM-3) in Psoriasis.
Griffiths CE; Boffa MJ; Gallatin WM; Martin S
Acta Derm Venereol; 1996 Jan; 76(1):2-5. PubMed ID: 8721479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]